InsiderTrades

Form 4 for ETON Eton Pharmaceuticals, Inc.

Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-19 · accession 0001437749-25-027464 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-08-20 2025-08-19+ ETON Gruber James R. CFO S - Sale $16.15 -41.7K 205.3K -17% -$673.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-20 S D 2,631 $16.02 204,753 D — — (F2) The shares were sold in multiple trades at prices ranging from $15.90 to $16.19. The price reported above reflects the weighted average sales price. (F3) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. (F1) The shares were sold in multiple trades at prices ranging from $16.01 to $16.43. The price reported above reflects the weighted average sales price.
2 Common Common Stock 2025-08-19 S D 39,082 $16.16 205,299 D — — (F2) The shares were sold in multiple trades at prices ranging from $15.90 to $16.19. The price reported above reflects the weighted average sales price. (F3) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. (F1) The shares were sold in multiple trades at prices ranging from $16.01 to $16.43. The price reported above reflects the weighted average sales price.